Allele frequencies of HLA-A, HLA-B, and HLA-DR alleles with (nearly) significant difference between controls and EBV+ or EBV− cHL subgroups
. | Controls . | EBV+ cHL . | EBV− cHL . | Controls vs EBV+ (P) . | Controls vs EBV− (P) . | |||
---|---|---|---|---|---|---|---|---|
n . | % . | n . | % . | n . | % . | |||
HLA-A1 | 2667 | 18.8 | 52 | 33.3 | 85 | 13.0 | < .00001† | NS |
HLA-A2 | 4828 | 34.0 | 25 | 16.0 | 153 | 33.0 | < .00001† | NS |
HLA-A68(28) | 124 | 0.9 | 5 | 3.2 | 26 | 5.6 | .0021† | < .000001† |
HLA-B37 | 277 | 1.9 | 13 | 8.4 | 10 | 2.2 | < .000001† | NS |
HLA-B51(5)* | 745 | 5.1 | 14 | 7.4 | 33 | 9.1 | NS | NS |
HLA-B60(40) | 1037 | 7.1 | 8 | 5.2 | 15 | 3.4 | NS | .0022‡ |
HLA-DR4 | 2146 | 18.1 | 26 | 16.7 | 55 | 11.9 | NS | .00063† |
HLA-DR7 | 1320 | 11.1 | 7 | 4.5 | 26 | 5.6 | NS | .00019† |
HLA-DR10 | 118 | 1.0 | 6 | 3.8 | 5 | 1.1 | .00047† | NS |
HLA-DR11(5) | 87 | 0.7 | 7 | 4.5 | 60 | 13.0 | < .000001† | < .000001† |
HLA-DR15(2) | 1690 | 14.3 | 27 | 17.3 | 104 | 22.5 | NS | .000001† |
. | Controls . | EBV+ cHL . | EBV− cHL . | Controls vs EBV+ (P) . | Controls vs EBV− (P) . | |||
---|---|---|---|---|---|---|---|---|
n . | % . | n . | % . | n . | % . | |||
HLA-A1 | 2667 | 18.8 | 52 | 33.3 | 85 | 13.0 | < .00001† | NS |
HLA-A2 | 4828 | 34.0 | 25 | 16.0 | 153 | 33.0 | < .00001† | NS |
HLA-A68(28) | 124 | 0.9 | 5 | 3.2 | 26 | 5.6 | .0021† | < .000001† |
HLA-B37 | 277 | 1.9 | 13 | 8.4 | 10 | 2.2 | < .000001† | NS |
HLA-B51(5)* | 745 | 5.1 | 14 | 7.4 | 33 | 9.1 | NS | NS |
HLA-B60(40) | 1037 | 7.1 | 8 | 5.2 | 15 | 3.4 | NS | .0022‡ |
HLA-DR4 | 2146 | 18.1 | 26 | 16.7 | 55 | 11.9 | NS | .00063† |
HLA-DR7 | 1320 | 11.1 | 7 | 4.5 | 26 | 5.6 | NS | .00019† |
HLA-DR10 | 118 | 1.0 | 6 | 3.8 | 5 | 1.1 | .00047† | NS |
HLA-DR11(5) | 87 | 0.7 | 7 | 4.5 | 60 | 13.0 | < .000001† | < .000001† |
HLA-DR15(2) | 1690 | 14.3 | 27 | 17.3 | 104 | 22.5 | NS | .000001† |